In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014–2019)

OBJECTIVES: To evaluate the in vitro antibacterial activity of cefiderocol, a siderophore cephalosporin against MBL-producing clinical isolates. METHODS: MBL-producing strains were selected from clinical isolates of Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii complex collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemura, Miki, Wise, Mark G, Hackel, Meredith A, Sahm, Daniel F, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393876/
https://www.ncbi.nlm.nih.gov/pubmed/37390312
http://dx.doi.org/10.1093/jac/dkad200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393876/
https://www.ncbi.nlm.nih.gov/pubmed/37390312
http://dx.doi.org/10.1093/jac/dkad200

Ejemplares similares